The global dipeptidyl peptidase 4 (DPP-4) inhibitors market is anticipated to grow significantly at a CAGR of 3.5% over the forecast period (2024-2031). The global dipeptidyl peptidase 4 (DPP-4) inhibitors market is sectioned on the basis of drug type. The market is sectioned as Sitagliptin, Vildagliptin, Saxagliptin, Linagliptin, Gemigliptin, Anagliptin, Teneligliptin, and Others. Amongst these drug types […]
Tag Archives: Dipeptidyl Peptidase 4 (DPP-4) Inhibitors Market
The global dipeptidyl peptidase-4 (DPP-4) inhibitors market is anticipated to grow at a significant CAGR during the forecast period. The major factors that are expected to boost the market growth include increasing incidences of diabetes, particularly type-2 diabetes, as well as an increase in obesity populations. Moreover, an increase in clinical trials on the DPP-4 […]
The global dipeptidyl peptidase 4 (DPP-4) inhibitors market is anticipated to grow significantly at a CAGR of 3.5% over the forecast period (2020-2026). The global dipeptidyl peptidase 4 (DPP-4) inhibitors market is sectioned on the basis of drug type. The market is sectioned as Sitagliptin, Vildagliptin, Saxagliptin, Linagliptin, Gemigliptin, Anagliptin, Teneligliptin, and Others. Amongst these […]